ES2160834T3 - Derivado de fenil pirimidina opticamente activo como agente analgesico. - Google Patents

Derivado de fenil pirimidina opticamente activo como agente analgesico.

Info

Publication number
ES2160834T3
ES2160834T3 ES96931006T ES96931006T ES2160834T3 ES 2160834 T3 ES2160834 T3 ES 2160834T3 ES 96931006 T ES96931006 T ES 96931006T ES 96931006 T ES96931006 T ES 96931006T ES 2160834 T3 ES2160834 T3 ES 2160834T3
Authority
ES
Spain
Prior art keywords
pirimidine
phenyl
derivative
optically active
analgesic agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96931006T
Other languages
English (en)
Inventor
Malcolm Stuart Nobbs
Sandra Jane Rodgers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of ES2160834T3 publication Critical patent/ES2160834T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Abstract

UNA PIRIMIDINA DE FORMULA (I) Y LAS SALES DE ADICION ACIDAS FARMACEUTICAMENTE ACEPTABLES DE LA MISMA SON UTILES COMO ANALGESICOS, ANTICONVULSIONANTES, O EN EL TRATAMIENTO DEL SINDROME DE INTESTINO IRRITABLE O TRASTORNO BIPOLAR.
ES96931006T 1995-09-05 1996-09-03 Derivado de fenil pirimidina opticamente activo como agente analgesico. Expired - Lifetime ES2160834T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9518027.9A GB9518027D0 (en) 1995-09-05 1995-09-05 Pharmacologically active compound

Publications (1)

Publication Number Publication Date
ES2160834T3 true ES2160834T3 (es) 2001-11-16

Family

ID=10780172

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96931006T Expired - Lifetime ES2160834T3 (es) 1995-09-05 1996-09-03 Derivado de fenil pirimidina opticamente activo como agente analgesico.

Country Status (32)

Country Link
US (1) US6124308A (es)
EP (1) EP0879230B1 (es)
JP (1) JPH11512108A (es)
KR (1) KR19990044397A (es)
CN (1) CN1200729A (es)
AP (1) AP640A (es)
AR (1) AR004192A1 (es)
AT (1) ATE203523T1 (es)
AU (1) AU710091B2 (es)
BG (1) BG65102B1 (es)
BR (1) BR9610388A (es)
CA (1) CA2230362A1 (es)
CO (1) CO4750651A1 (es)
CZ (1) CZ65598A3 (es)
DE (1) DE69614150T2 (es)
EA (1) EA000695B1 (es)
ES (1) ES2160834T3 (es)
GB (1) GB9518027D0 (es)
HR (1) HRP960399A2 (es)
HU (1) HUP9901260A3 (es)
ID (1) ID17274A (es)
IL (1) IL123414A0 (es)
IS (1) IS4673A (es)
NO (1) NO980923L (es)
NZ (1) NZ318390A (es)
PL (1) PL325329A1 (es)
SK (1) SK28598A3 (es)
TR (1) TR199800386T1 (es)
TW (1) TW367326B (es)
WO (1) WO1997009317A2 (es)
YU (1) YU49796A (es)
ZA (1) ZA967466B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR016212A1 (es) * 1998-04-28 2001-06-20 Astra Ab Uso de compuestos farmaceuticos que tienen una actividad antagonista de nmda para preparar un medicamento para el tratamiento del sindrome de intestino irritable (ibs), y composiciones farmaceuticas
US6420354B1 (en) 1998-06-08 2002-07-16 Advanced Medicine, Inc. Sodium channel drugs and uses
AU4550699A (en) * 1998-06-08 1999-12-30 Advanced Medicine, Inc. Multibinding agents that modulate the 5-ht transporter
GB9907965D0 (en) * 1999-04-09 1999-06-02 Glaxo Group Ltd Medical use
US6479498B1 (en) 1999-06-04 2002-11-12 Theravance, Inc. Sodium channel drugs and uses
CA2416819C (en) * 2000-07-21 2011-03-22 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
EP1390355A4 (en) 2001-02-27 2005-02-23 Teva Pharma NEW CRYSTALLINE FORMS OF LAMOTRIGIN AND METHOD FOR THE PRODUCTION THEREOF
EP2266590A3 (en) 2002-02-22 2011-04-20 Shire LLC Active agent delivery sytems and methods for protecting and administering active agents
US20050238724A1 (en) * 2002-04-23 2005-10-27 Teva Pharmaceutical Industries Ltd. Pharmaceutical composition containing lamotrigine particles of defined morphology
CA2514574A1 (en) * 2003-01-30 2004-08-12 Dynogen Pharmaceuticals, Inc. Use of sodium channel modulators for treating gastrointestinal tract disorders
GB0603087D0 (en) * 2006-02-15 2006-03-29 Glaxo Group Ltd Novel use
EP2129381A1 (en) 2007-01-24 2009-12-09 Glaxo Group Limited Pharmaceutical compositions comprising 3, 5-diamin0-6- (2, 3-dichl0phenyl) -l, 2, 4-triazine or r (-) -2, 4-diamino-5- (2, 3-dichlorophenyl) -6-fluoromethyl pyrimidine and an nk1
GB201111712D0 (en) 2011-07-08 2011-08-24 Gosforth Ct Holdings Pty Ltd Pharmaceutical compositions

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK153787C (da) * 1979-06-01 1989-01-16 Wellcome Found Analogifremgangsmaade til fremstilling af substituerede 3,5-diamino-6-phenyl-1,2,4-triaziner og alfa-cyanobenzyliden-aminoguanidinforbindelser til anvendelse som mellemprodukter herved
FI895821A0 (fi) * 1988-12-07 1989-12-05 Wellcome Found Farmaceutiskt aktiva cns foereningar.

Also Published As

Publication number Publication date
AR004192A1 (es) 1998-11-04
EA199800189A1 (ru) 1998-10-29
AP640A (en) 1998-04-14
HRP960399A2 (en) 1998-04-30
MX9801680A (es) 1998-05-31
CA2230362A1 (en) 1997-03-13
ID17274A (id) 1997-12-18
CN1200729A (zh) 1998-12-02
AU6986596A (en) 1997-03-27
BG65102B1 (bg) 2007-02-28
EP0879230B1 (en) 2001-07-25
US6124308A (en) 2000-09-26
CO4750651A1 (es) 1999-03-31
PL325329A1 (en) 1998-07-20
EP0879230A2 (en) 1998-11-25
HUP9901260A2 (hu) 1999-09-28
NZ318390A (en) 1999-02-25
GB9518027D0 (en) 1995-11-08
IS4673A (is) 1998-02-23
HUP9901260A3 (en) 2001-04-28
WO1997009317A3 (en) 1997-04-03
WO1997009317A2 (en) 1997-03-13
NO980923L (no) 1998-05-04
DE69614150T2 (de) 2001-11-22
TW367326B (en) 1999-08-21
NO980923D0 (no) 1998-03-04
JPH11512108A (ja) 1999-10-19
TR199800386T1 (xx) 1998-05-21
KR19990044397A (ko) 1999-06-25
AU710091B2 (en) 1999-09-16
AP9600857A0 (en) 1996-10-31
BG102342A (en) 1998-09-30
DE69614150D1 (de) 2001-08-30
BR9610388A (pt) 1999-07-06
EA000695B1 (ru) 2000-02-28
IL123414A0 (en) 1998-09-24
YU49796A (sh) 1999-07-28
SK28598A3 (en) 1998-09-09
ATE203523T1 (de) 2001-08-15
CZ65598A3 (cs) 1998-07-15
ZA967466B (en) 1998-04-06

Similar Documents

Publication Publication Date Title
ES2160834T3 (es) Derivado de fenil pirimidina opticamente activo como agente analgesico.
CY1110019T1 (el) Συνδυασμενη θεραπεια με υποκατεστημενες οξαζολιδινονες
NO994409L (no) Stabilisering av syresensitive benzimidazoler med aminosyre/cyklodekstrin-kombinasjoner
CY1116464T1 (el) Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης
DE59911740D1 (de) Topisch anwendbare mittel gegen nagelpilzerkrankungen
BR0112750A (pt) Aminopiperidina quinolinas e seus análogos azaisostéricos com atividade antibacteriana
AR039511A1 (es) Agentes que regulan, inhiben, o modulan la actividad y/o la expresion del factor de crecimiento del tejido conjuntivo (ctgf) como unico medio para disminuir la presion intraocular y para tratar las retinopatias glaucomatosas/neuropatias opticas
ATE336995T1 (de) Aminocyclohexenchinoline und ihre azaisosterischen analoga mit antibakterieller wirkung
DK0806941T3 (da) Liposomalt antibakterielt præparat med lav fasthed
SE9900961D0 (sv) Novel compounds
CY1107465T1 (el) Μελαγατρανη για τη θepαπευτικη αντιμετωπιση φλεγμονων
ES2083597T3 (es) Preparacion farmaceutica para el tratamiento del tiempo de coagulacion prolongado.
ATE287267T1 (de) Kombinationstherapien mit gefässschädigender aktivität
EA200200742A1 (ru) 1,2-диарилбензимидазолы для лечения заболеваний, связанных с активацией микроглии
CY1109001T1 (el) Οι καππα-οπιοιδεις αγωνιστες στη θεραπεια των παθησεων της κυστης
TR200200473T2 (tr) Rar selektif retinoid agonistleri.
AR002272A1 (es) Uso de amidas de fenilciclohexilcarboxilicos
ES2175006T3 (es) N-(pirimidinil)-benzosulfonamidas como medicamentos.
DE50113974D1 (de) Kombinationspräparate von 3-n-formylhydroxylaminopropylphosphonsäurederivaten oder 3-n-acetylhydroxylaminopropylphosphonsäurederivaten mit speziellen pharmazeutischen wirkstoffen
RS49520B (sr) Antimikrobno aktivne smeše
ES2061821T3 (es) Utilizacion terapeutica del derivado ester isopropilo de monosialgangliosido en patologias nerviosas con componente inflamatoria.
ATE491709T1 (de) Pyrrolidinohydrochinazoline
PT1059845E (pt) Composicao fungicida compreendendo uma benzoilfenilureia
EA200100010A1 (ru) Местное применение оксазолидинонов для трансдермальной доставки
CY1118235T1 (el) Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ii

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 879230

Country of ref document: ES